Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD introduces new packaging surveillance scheme
The regulator will now monitor products which are already on the market.
New ‘streamlined’ regulation will launch on 2 February 2026.

The Veterinary Medicines Directorate (VMD) is to introduce a new veterinary medicines packaging surveillance scheme, which is expected to streamline the regulation process.

The new scheme, which launches from 2 February 2026, will change how the VMD assesses and monitors medicine packaging. The regulator will now monitor products which are already on the market, ensuring proportionate oversight without unnecessary burden.

Every three months, a selection of products will be chosen for a packaging assessment. The products will be taken from wholesalers, and every packaging component will be reviewed.

The assessment verifies whether the packaging is compliant with approved product information text (QRD) and principles set out in the Product Literature Standards.

Findings will be shared with the Market Authorisation Holder (MAH) within the three-month assessment period. If non-compliance is identified, corrective actions will be sent – varying from updating packaging, submission of a formal variation, and tracking product defects.

The timeframe for implementing actions is dependent on the severity of identified issues.

The VMD will also no longer require mock-ups for G.I.18 Variations Requiring Assessments (VRA) and during a new Marketing Authorisation (MA) procedure. However it will continue to review mock-ups which are introduced prior to marketing, undertake joint assessment of mock-ups ahead of a new MA, and assess significant changes to design or layout which are unrelated to SPCs.

If a mock-up is required, only those which are for the smallest marketed pack size should be submitted.

The VMD says it will not routinely assess or annotate mock-ups for other variation categories. However, it may request other mock-ups on a case-by-case basis.

More details can be found on the VMD website.

Image © PeopleImages/Shutterstock.com

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.